Here’s a truth die hard naturalists have a hard time accepting: you can do everything “right,” eat perfectly, exercise daily, and live the healthiest lifestyle imaginable and still get sick. That doesn’t mean healthy habits don’t matter. It means disease is complex. Genetics, environment, chance, and biology all play a role.
🆕 @NatureMedicine
How does ChatGPT Health do for appropriately triaging a person as to whether to go to the emergency room or stay home? https://t.co/2FN3qxEivx
Not very well. Under-triaged 52% of case vignettes that are considered gold-standard emergencies, like diabetic ketoacidosis or impending respiratory failure
@jmanuelverdugo@doctormacias Entiendo el punto. El problema es que señalar o avergonzar no reduce la obesidad; la evidencia muestra que suele alejar a las personas del sistema de salud. Es mejor reconocerla como una enfermedad compleja y tratable, sin culpabilizar a quien la vive.
@jmanuelverdugo@doctormacias Considerando que más del 70% de la población adulta en México tiene cierto grado de sobrepeso u obesidad, y la definición de “normal” es habitual u ordinario; ¿A qué te refieres con “normalizar la obesidad”?
@carlos_arnaud@TheLancet Me sorprende que la paroxetina la cataloguen como fármaco que favorece la pérdida de peso cuando hay otros estudios que indican lo contrario
@moy_qmac Es interesante que insista tanto en dialéctica cuando su argumento se basa en una falacia de falso dilema temporal (o falacia de la comparación relativa)
Telling someone to lose weight without helping them or guiding them on how to do that is like telling someone to build a house without giving them tools, then judging them for being homeless.
🕵️♂️ Look at how many new obesity management medications (OMMs) are on the way! Injectables (daily, weekly, monthly), orals, duals G, triples G... GLP-1 + amylin, GLP-1 + human monoclonal antibody (not in the chart) combos. And interestingly, it’s not just the usual big names, many new companies are entering the space too. 💪
.
The whole thing feels like when ACE inhibitors and ARBs first took off in hypertension care. A wave of innovation, new targets, new options.
.
No matter your background specialty/subspecialty, obesity medicine is becoming a space worth watching!
.
Source article link in the pic.